nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

Open Access 01.04.2010 | Article

Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction

verfasst von: T. J. Meerhoff, M. L. Houben, F. E. J. Coenjaerts, J. L. L. Kimpen, R. W. Hofland, F. Schellevis, L. J. Bont

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2010

Abstract

In this study, we present the multiple detection of respiratory viruses in infants during primary respiratory illness, investigate the sensitivity of nasal swabs and nasopharyngeal aspirates, and assess whether patient characteristics and viral load played a role in the sensitivity. Healthy infants were included at signs of first respiratory tract infection. Paired nasopharyngeal aspirates and nasal swabs were collected. Real-time polymerase chain reaction (PCR) was carried out for 11 respiratory pathogens. Paired nasopharyngeal aspirates and nasal swabs were collected in 98 infants. Rhinovirus (n = 67) and respiratory syncytial virus (n = 39) were the most frequently detected. Co-infection occurred in 48% (n = 45) of the infants. The sensitivity of the nasal swab was lower than the nasopharyngeal aspirate, in particular, for respiratory syncytial virus (51% vs. 100%) and rhinovirus (75% vs. 97%). The sensitivity of the nasal swab was strongly determined by the cycle threshold (CT) value (p < 0.001). The sensitivity of the swab for respiratory syncytial virus, but not rhinovirus, was 100% in children with severe symptoms (score ≥11). It is concluded that, for community-based studies and surveillance purposes, the nasal swab can be used, though the sensitivity is lower than the aspirate, in particular, for the detection of mild cases of respiratory syncytial virus (RSV) infection.

Nasal swab

NPA

Nasopharyngeal aspirate

PCR

Polymerase chain reaction

hMPV

Human metapneumovirus

RSV

Respiratory syncytial virus

Background

Respiratory viruses are a common cause of illness in children, in particular during their first years of life, and may lead to more severe morbidity and hospitalisation [1‐4]. Different types of specimen are available for viral diagnosis. The nasopharyngeal aspirate (NPA) has been considered to be the best sampling technique, but is more invasive and results in significantly more distress of the infant than a nasal swab (NS) [5]. A number of studies have compared the sensitivity of the NPA with nasopharyngeal swabs [6], nose–throat swabs [7] and NS [5, 8‐10]. Generally, conventional techniques such as viral culture and antigen detection methods were used. The use of real-time polymerase chain reaction (PCR) may overcome differences in sensitivity for respiratory viruses as a result of specimen type [7].

Limited data are available on the comparison of these sampling methods combined with real-time PCR. It was observed that nose–throat swabs are a less invasive diagnostic technique, with adequate sensitivity for use in outpatient and large community-based settings in children [7]. However, no tests were performed for rhinovirus, even though this virus commonly infects infants [11]. The aim of this study was to present the detection of common respiratory pathogens in infants during primary respiratory illness, to investigate the sensitivity of the NS and NPA, and assess the role of patient characteristics and viral load in the sensitivity of either sampling method.

Study design

Study cohort

The study is part of the Netherlands Amnion Fluid Study of the Utrecht University Medical Centre (UUMC), the Netherlands [12]. Healthy infants were included at birth and were at risk for primary respiratory infection until the age of one year. The data collection and episode sampling stopped one year after birth. From April 2006 to April 2008, including two winter seasons, paired NPA and NS specimens were obtained from 98 infants. Parents were instructed to notify the clinical staff within 24 h after the onset of symptoms. Clinical staff visited the child within 36 h and the history of illness was taken by a standardised questionnaire. Symptoms were scored, according to Gern et al. [13], with points presented in parentheses: fever (>38°C) (1); cough, mild (1), moderate (2), severe (3); rhinorrhoea, mild (1), moderate to severe (2); hoarseness (1); duration of illness >4 days (1); apnoea (3); wheezing (5); retractions (5); tachypnoea (5); cyanosis (5). Mild, moderate and severe infection were defined as sum scores 0–4, 5–10 and 11 and higher, respectively. Specially trained clinical staff obtained paired NS and NPA.

Collection of specimens

The NPA was obtained by the use of an infant mucus extractor (Vygon). Both nostrils were suctioned. In addition, an NS was collected; samples were collected from one nostril and one from the hard palate using separate cotton-tipped swabs (Infant Mucus Extractor, Vygon Pharmaceutiques, Ecouen, France). The two swabs were then inserted into one vial containing 2 ml of virus transport medium (Gly medium).

Real-time PCR

Semi-quantitative real-time PCR was conducted on both the NS and NPA for respiratory syncytial virus (RSV), rhinovirus, human metapneumovirus, adenovirus, coronavirus, influenza, parainfluenza virus (type 1, 3), parainfluenza (type 2, 4), bocavirus, Mycoplasma pneumoniae and Chlamydia pneumoniae. Nucleic acids were extracted using the QIAamp DSP virus kit (QIAGEN, Valencia, CA, USA). Each sample was eluted in 200 μl buffer. cDNA was synthesised by using MultiScribe reverse transcriptase (RT) and random hexamers (both from Applied Biosystems, Foster City, CA, USA) [14]. Each 100-μl reaction mixture contained 60 μl cDNA mix and 40 μl of eluted RNA. After incubation for 10 min at 25°C, RT was carried out for 30 min at 48°C, followed by RT inactivation for 5 min at 95°C [14]. Samples were assayed in a 50-μl reaction mixture containing 20 μl (c)DNA and a 30-μl mix of the forward and reverse primers and probes. All samples had been spiked before extraction with an internal control virus (murine encephalomyocarditis virus [RNA] and phocine herpes virus [DNA]). The amplification and detection were performed by the use of an ABI Prism 7700 sequence-detection system; 2 min at 50°C to acquire optimal AmpErase UNG activity and 10 min at 95°C to activate AmpliTaq Gold DNA polymerase, followed by 45 cycles of 15 s at 95°C and 1 min at 60°C [15]. Primers and probes for the real-time PCR detection of RSV, influenza virus, parainfluenza virus and adenovirus are available from van de Pol et al. [16] and real-time PCR assays were performed as described previously [17‐19].

Statistical analysis

Similar to previous studies, a consensus standard was used to assess the sensitivity of each testing method: a positive result in either the NPA or NS was considered as the gold standard for the presence of a pathogen and was used to calculate the sensitivity of the NPA and NS for the detection of the respiratory pathogens. The Chi-square test was used and a logistic regression analysis was performed. The outcome variable was defined as the sample being positive. Variables used in the model were age, gender, symptom score and multiple virus detection. Statistical significance was concluded if the p-value was <0.05. The statistical analyses were performed in STATA 10.0 (StataCorp LP, College Station, TX, USA).

Results

A total of 163 respiratory pathogens were identified in 94 children. The majority of children (73.5%) were ill for less than 4 days at the time of sampling. The median age at primary infection was 104 days (range 33–269) and the median score of symptoms was 3, indicating a mild illness (Table 1). In all children with an illness of 5 days or longer, one or more pathogens were detected.

Table 1

Characteristics of infants during the first airway infection

Characteristics	All infants (N = 98)	Rhinovirus detected (n = 67)	RSV detected (n = 39)
Median age in days (range)	104 (33–269)	99 (33–269)	115 (51–269)
Median days of illness at time sampling (range)	3.5 (2–31)^c	4 (2–16)	4 (2–12)
% male	58%	60%	62%
Symptoms
Rhinorrhoea
None	15%	15%	18%
Mild	55%	58%	46%
Moderate–severe	30%	27%	36%
Cough
None	17%	18%	5%
Mild	36%	46%	28%
Moderate	37%	30%	46%
Severe	10%	6%	21%
Wheezing^a	8%	6%	10%
Fever >38°C	17%	12%	23%
Hoarseness	28%	22%	31%
Apnoea^b	3%	2%	5%
Cyanosis	1%	0%	3%
Retractions	6%	3%	5%
Tachypnoea	20%	16%	28%
Median sum score (range)	3 (0–25)	3 (0–15)	4 (1–25)
0–4	64%	72%	56%
5–10	25%	22%	26%
>10	11%	6%	18%

The values represent percentages, unless indicated otherwise

^aReported by parents

^bN = 97

^cDuration of illness: IQR = 3–5

Multiple pathogens in half of the children

In 49 children (50%), one pathogen was detected: 29 rhinovirus, 11 RSV, four coronavirus, two hMPV, two parainfluenza virus type 2 and 4, and one bocavirus. In 25 children, two pathogens were detected, of which 24 (96%) were rhinovirus with RSV. In 20 children, more than two pathogens were detected during the first episode of respiratory symptoms (three pathogens: n = 17; four pathogens: n = 2; five pathogens: n = 1). Co-infection rates by pathogen were: rhinovirus (57%), hMPV (60%), RSV (72%), coronavirus (71%) and bocavirus (91%).

Sensitivity of nasal swab is lower than the aspirate for RSV and rhinovirus

Rhinovirus was found the most frequently (n = 67), followed by RSV (n = 39) and coronavirus (n = 14) (Table 2). No influenza viruses or parainfluenza type 1 and 3 viruses were detected. The sensitivity for detecting any pathogen of the NPA was 92% (CI_95% 86.7–95.7), whereas the sensitivity of the NS was lower at 67% (CI_95% 59.1–74.0). For the detection of RSV and rhinovirus, the sensitivity of the NS was lower than the NPA (Table 2).

Table 2

Detection of respiratory pathogens and the sensitivity by sampling method

Respiratory pathogen	NPA (n)	NS (n)	Total	NPA		NS
Respiratory pathogen	NPA (n)	NS (n)	Total	Sensitivity	95% CI*	Sensitivity	95% CI*
Rhinovirus	65	50	67	97%	89.6–99.6	75%	62.5–84.4
RSV	39	20	39	100%	91.0–100	51%	34.8–67.6
Coronavirus	13	10	14	93%	66.1–99.8	71%	41.9–91.6
Bocavirus	8	7	11	73%	39.0–94.0	64%	30.8–89.1
Adenovirus	9	6	11	82%	48.2–97.7	55%	23.4–83.3
Parainfluenza type 2 and 4	9	9	11	82%	48.2–97.7	82%	48.2–97.7
hMPV	4	3	5	80%	28.4–99.5	60%	14.7–94.7
Mycoplasma pneumoniae	2	2	3	67%	9.4–99.2	67%	9.4–99.2
Chlamydia pneumoniae	1	2	2	50%	1.2–98.7	100%	15.8–100
Total	150	109	163	92%	86.7–95.7	67%	59.1–74.0

NPA: nasopharyngeal aspirate; NS: nasal swab; RSV: respiratory syncytial virus; hMPV: human metapneumovirus; CI: confidence interval

*A one-sided 97.5% confidence interval was used in case the sensitivity was 100%

Sensitivity of nasal swab depends on viral load

The sensitivity values of the NPA and NS were investigated in more detail for rhinovirus and RSV (Table 3). For children with a low symptom score, the sensitivity of the NS was lower than the NPA. The NS had a lower sensitivity than the NPA for the 30–40 cycle threshold (CT) values. To assess whether the sensitivity of the NS differed by age group, gender, multiple pathogens, symptom score and CT value, Chi-squared tests were performed. The sensitivity of the NS for the detection of RSV was related to the symptom score (p = 0.001) and the sensitivity of the NS was related to the CT values for both RSV and rhinovirus (p < 0.001).

Table 3

Sensitivity of the NPA and NS for the detection of rhinovirus and RSV presented by age group, gender, symptom score, presence of multiple pathogens and CT-value of the NPA

Respiratory pathogen	subgroups	NPA	NTS	Total	NPA		NS
Respiratory pathogen	subgroups	(n)	(n)	Total	Sensitivity	95% CI^a	Sensitivity	95% CI^a
Rhinovirus
Age	1–3 months	28	24	28	100%	87.7–100	86%	67.3–96.0
	3–6 months	30	22	32	94%	79.2–99.2	69%	50.0–83.9
	6–12 months	7	4	7	100%	59.0–100	57%	18.4–90.1
Gender	Boy	38	32	40	95%	83.1–99.4	80%	64.4–90.0
Gender	Girl	27	18	27	100%	82.1–100	67%	46.0–83.5
Symptom score	0 to 4	46	36	48	96%	85.7–99.5	75%	60.4–86.4
	5 to 10	15	11	15	100%	78.2–100	73%	44.9–92.2
	over 11	4	3	4	100%	39.8–100	75%	19.4–99.4
Multiple pathogen	No	29	25	29	100%	88.1–100	86%	68.3–96.1
Multiple pathogen	Yes	36	25	38	95%	82.3–99.4	66%	48.7–80.4
CT NPA^b	0–20	3	3	3	100%	29.2–100	100%	29.2–100
	20–25	22	22	22	100%	84.6–100	100%	84.6–100
	25–30	17	15	17	100%	80.4–100	88%	63.6–98.5
	30–35	10	6	10	100%	69.2–100	60%	26.2–87.8
	35–40	10	2	10	100%	69.2–100	20%	2.5–55.6
	40–45	3	0	3	100%	2.9–100	0%	0–70.8
RSV
Age	1–3 months	12	7	12	100%	73.5–100	58%	27.7–84.8
	3–6 months	20	11	20	100%	82.3–100	55%	31.5–77.0
	6–12 months	7	2	7	100%	59.0–100	29%	7.6–64.8
Gender	Boy	24	11	24	100%	85.8–100	46%	25.6–67.2
Gender	Girl	15	9	15	100%	78.2–100	60%	32.3–83.4
Symptom score	0 to 4	22	8	22	100%	84.6–100	36%	17.2–59.3
	5 to 10	10	5	10	100%	69.2–100	50%	18.7–81.3
	over 11	7	7	7	100%	59.0–100	100%	59.0–100
Multiple pathogen	No	11	10	11	100%	71.5–100	91%	58.7–99.8
Multiple pathogen	Yes	28	10	28	100%	87.7–100	36%	18.6–56.0
CT NPA^b	0–20	4	4	4	100%	39.8–100	100%	39.8–100
	20–25	11	10	11	100%	71.5–100	91%	58.7–99.8
	25–30	4	4	4	100%	39.8–100	100%	39.8–100
	30–35	7	1	7	100%	59.0–100	14%	0.4–57.9
	35–40	10	0	10	100%	69.2–100	0%	0–30.8
	40–45	3	1	3	100%	29.2–100	33%	0.8–90.6

NPA nasopharyngeal aspirate; NS nasal swab; RSV respiratory syncytial virus; CT Cycle threshold value

^aOne-sided 97.5% confidence interval was used in case sensitivity was 100%

^bThe CT-value of the NPA was used as a reference to compare with NS, therefore the sensitivity of the NPA is 100% for all categories

In the logistic regression analysis, age and gender did not significantly predict the detection of RSV or rhinovirus. The symptom score predicted RSV detection in both the NPA (odds ratio [OR]: 1.21; CI_95% 1.07–1.39) and the NS (OR: 1.28; CI_95% 1.12–1.48), while an inverse relationship was observed for symptom score and rhinovirus detection in the two samples (OR: 0.87; CI_95% 0.78–0.98). The presence of more than one pathogen predicted RSV (OR: 8.98; CI_95% 3.03–26.7) or rhinovirus detection (OR: 3.66 CI_95% 1.33–10.08) in the NPA. When the same analysis was performed as a backwards regression with p < 0.2, the results did not change.

Discussion

This study illustrates that the proportion of infants where a respiratory pathogen is detected was high (96%) and co-infections were common. In 20 children, more than two pathogens were detected during the first episode of respiratory symptoms. Co-infections were observed frequently for RSV (72%), coronavirus (71%) and bocavirus (91%) in particular.

High rates of co-infection in young children have been described recently for childhood pneumonia, in particular, in children aged less than 12 months [20] and in children hospitalised with acute respiratory tract infection [21, 22]. The most frequently detected virus was RSV, followed by human bocavirus and rhinovirus [21, 23]. A common combination has been reported to be RSV and bocavirus [21]. Even though a high occurrence of co-infections has been reported, ranging from 14–16% [21, 22] to 27% [20], our study presents an even higher rate of co-infection. A possible explanation for this high co-infection rate may be related to the sampling of both nostrils for the NPA. Human bocavirus is a newly identified virus and has been detected in respiratory tract secretions in patients with acute respiratory symptoms in 2 to 19% of the samples [24]. Co-infection with another virus has been observed in 40% of bocavirus-positive children [25]. The frequent associations of bocavirus with other respiratory viruses might be explained by the persistence of bocavirus in the respiratory tract [25].

Furthermore, we investigated the sensitivity of the NPA and NS tested by a real-time PCR method. The sensitivity of the NPA was 92%, while for the NS, it was 67%. In particular for the detection of rhinovirus and RSV, the NS had a lower sensitivity (75% and 51%, respectively) compared to the NPA (97% and 100%, respectively). The sensitivity of the NS for RSV was 100% for children with high symptom scores. For both RSV and rhinovirus, viral load, indicated by the CT value, was the major determinant of the sensitivity of the NS in a dose-dependent fashion. The symptom score predicted RSV detection in both the NPA and the NS, while an inverse relationship was observed for symptom score and rhinovirus detection in the two samples.

The use of a swab has been considered as a suitable replacement in community-based research or epidemiological studies. The major advantage of a swab is that collection is less painful and more convenient than an aspirate, as no additional devices are needed [5]. These factors may outweigh some reduction in sensitivity. The advantage of molecular methods in the detection of respiratory viruses has been reported [26, 27] and Lambert et al. reported that using these methods seemed to overcome the previously observed sensitivity reduction when less invasive specimens were combined with the conventional laboratory methods [7]. With the recently developed flocked swabs, the sensitivity is even further improved and the flocked swabs have the advantage of being rapid and less traumatic for paediatric patients [28]. However, the sensitivity of the flocked swab in outpatient respiratory tract infections may be lower than in hospitalised patients. Further studies are required considering different types of swabs and patient populations, and should test for a broad spectrum of respiratory pathogens.

Our findings demonstrated a lower sensitivity of the NS, in particular for RSV. Similar results were reported in other studies where conventional, non-amplification-based methods were used [8, 9]. Lambert et al. did not test for rhinovirus and this was the most frequently detected virus in our study and elsewhere [11, 29]. No influenza detections were found in our study. This is not explained by sampling bias, because most swabs were taken during the winter season, during which both RSV and influenza had their peak incidence. A possible reason may be related to the patient population and the small population size. Another study showed similar results, with rhinovirus and RSV being the most frequently detected [29].

There were a number of limitations of this study. Firstly, one limitation was the timing of sampling. For five cases, sampling occurred 10 days after the onset of illness. Since the viral shedding of RSV is highest between days 0 and 6, sampling should preferably occur in this period [30]. The high proportion of positive samples, however, indicates that this effect was not a major drawback of this study. Secondly, in this study, pain and discomfort of the collection of the samples was not assessed, but other studies provided reference to this [5]. Finally, it is unknown whether the order of obtaining the specimens may have resulted in a lower detection rate in the NS. It is possible that, by suctioning both nostrils for the NPA, the secretions with virus or viral nucleic acids were reduced. This corresponds with the finding that few mild cases were detected with the NS, as the sensitivity of the NS dropped with lower symptoms score and higher CT values. Because the order and nature of the sample collection was slightly different from the study performed by Lambert et al., the sensitivity of the NS may be an underestimate, and caution needs to be taken when interpreting the NS sensitivity.

RSV and rhinovirus were commonly detected in infants during primary respiratory infection, and co-infections occurred in about half of the children. The sensitivity of the NPA was higher than the NS, in particular for the detection of RSV and rhinovirus. Although the sensitivity of a method is important, one must also take into account the advantages that different sampling methods offer. The great advantage of the NS is that this method can be performed in outpatient settings without needing special devices, is less costly and causes less distress for the patient than the NPA. Although there is a reduction in sensitivity for RSV, particularly in infants with mild symptoms, the NS is convenient for sampling patients in community studies and can be used for surveillance purposes.

Acknowledgement

This work was supported by grants from the Netherlands Asthma Foundation (grant no. 3.2.07.001), WKZ Research Fund (grant no. 2004.02) and a fellowship award of the European Society for Paediatric Infectious Diseases (ESPID).

The medical ethical committee of the Utrecht University Medical Centre (UUMC) approved the study protocol and written informed consent was obtained from the parents of the participating children.

Conflicts of interest

The authors declare that they have no conflicting interests in publishing this paper.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt testen ¹

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Jetzt testen ²

Bosis S, Esposito S, Niesters HG et al (2008) Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences. Clin Microbiol Infect 14(7):677–684CrossRefPubMed

Hall CB, Weinberg GA, Iwane MK et al (2009) The burden of respiratory syncytial virus infection in young children. N Engl J Med 360(6):588–598CrossRefPubMed

Izurieta HS, Thompson WW, Kramarz P et al (2000) Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342(4):232–239CrossRefPubMed

Miller EK, Lu X, Erdman DD et al (2007) Rhinovirus-associated hospitalizations in young children. J Infect Dis 195(6):773–781CrossRefPubMed

Macfarlane P, Denham J, Assous J et al (2005) RSV testing in bronchiolitis: which nasal sampling method is best? Arch Dis Child 90(6):634–635CrossRefPubMed

Ahluwalia G, Embree J, McNicol P et al (1987) Comparison of nasopharyngeal aspirate and nasopharyngeal swab specimens for respiratory syncytial virus diagnosis by cell culture, indirect immunofluorescence assay, and enzyme-linked immunosorbent assay. J Clin Microbiol 25(5):763–767PubMed

Lambert SB, Whiley DM, O’Neill NT et al (2008) Comparing nose-throat swabs and nasopharyngeal aspirates collected from children with symptoms for respiratory virus identification using real-time polymerase chain reaction. Pediatrics 122(3):e615–e620CrossRefPubMed

Heikkinen T, Marttila J, Salmi AA et al (2002) Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J Clin Microbiol 40(11):4337–4339CrossRefPubMed

Stensballe LG, Trautner S, Kofoed PE et al (2002) Comparison of nasopharyngeal aspirate and nasal swab specimens for detection of respiratory syncytial virus in different settings in a developing country. Trop Med Int Health 7(4):317–321CrossRefPubMed

10.

Waris ME, Heikkinen T, Osterback R et al (2007) Nasal swabs for detection of respiratory syncytial virus RNA. Arch Dis Child 92(11):1046–1047CrossRefPubMed

11.

Lambert SB, Allen KM, Druce JD et al (2007) Community epidemiology of human metapneumovirus, human coronavirus NL63, and other respiratory viruses in healthy preschool-aged children using parent-collected specimens. Pediatrics 120(4):e929–e937CrossRefPubMed

12.

Houben ML, Nikkels PG, van Bleek GM et al (2009) The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS One 4(8):e6572CrossRefPubMed

13.

Gern JE, Martin MS, Anklam KA et al (2002) Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol 13(6):386–393CrossRefPubMed

14.

van de Pol AC, Wolfs TF, Jansen NJ et al (2006) Diagnostic value of real-time polymerase chain reaction to detect viruses in young children admitted to the paediatric intensive care unit with lower respiratory tract infection. Crit Care 10(2):R61CrossRefPubMed

15.

van Elden LJ, van Loon AM, van Alphen F et al (2004) Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis 189(4):652–657CrossRefPubMed

16.

van de Pol AC, van Loon AM, Wolfs TF et al (2007) Increased detection of respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses with real-time PCR in samples from patients with respiratory symptoms. J Clin Microbiol 45(7):2260–2262CrossRefPubMed

17.

van Elden LJ, Nijhuis M, Schipper P et al (2001) Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 39(1):196–200CrossRefPubMed

18.

van Elden LJ, van Loon AM, van der Beek A et al (2003) Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults. J Clin Microbiol 41(9):4378–4381CrossRefPubMed

19.

20.

Cilla G, Oñate E, Perez-Yarza EG et al (2008) Viruses in community-acquired pneumonia in children aged less than 3 years old: High rate of viral coinfection. J Med Virol 80(10):1843–1849CrossRefPubMed

21.

Bonzel L, Tenenbaum T, Schroten H et al (2008) Frequent detection of viral coinfection in children hospitalized with acute respiratory tract infection using a real-time polymerase chain reaction. Pediatr Infect Dis J 27(7):589–594CrossRefPubMed

22.

Canducci F, Debiaggi M, Sampaolo M et al (2008) Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease. J Med Virol 80(4):716–723CrossRefPubMed

23.

Cilla G, Sarasua A, Montes M et al (2006) Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain. Epidemiol Infect 134(3):506–513CrossRefPubMed

24.

Schildgen O, Müller A, Allander T et al (2008) Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev 21(2):291–304; table of contentsCrossRefPubMed

25.

Brieu N, Guyon G, Rodière M et al (2008) Human bocavirus infection in children with respiratory tract disease. Pediatr Infect Dis J 27(11):969–973CrossRefPubMed

26.

Boivin G, Côté S, Déry P et al (2004) Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses. J Clin Microbiol 42(1):45–51CrossRefPubMed

27.

Freymuth F, Vabret A, Cuvillon-Nimal D et al (2006) Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. J Med Virol 78(11):1498–1504CrossRefPubMed

28.

Abu-Diab A, Azzeh M, Ghneim R et al (2008) Comparison between pernasal flocked swabs and nasopharyngeal aspirates for detection of common respiratory viruses in samples from children. J Clin Microbiol 46(7):2414–2417CrossRefPubMed

29.

Bueno Campaña M, Calvo Rey C, Vázquez Alvarez MC et al (2008) Viral respiratory tract infections in the first six months of life. An Pediatr (Barc) 69(5):400–405CrossRef

30.

Falsey AR, Formica MA, Treanor JJ et al (2003) Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol 41(9):4160–4165CrossRefPubMed

Titel: Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction
verfasst von: T. J. Meerhoff
M. L. Houben
F. E. J. Coenjaerts
J. L. L. Kimpen
R. W. Hofland
F. Schellevis
L. J. Bont
Publikationsdatum: 01.04.2010
Verlag: Springer-Verlag
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2010
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-009-0865-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen